BACKGROUND: Phenol-soluble modulins (PSMs) are amphipathic, pro-inflammatory proteins secreted by most Staphylococcus aureus isolates. This study tested the hypothesis that in vitro PSM production levels are associated with specific clinical phenotypes. METHODS: 177 methicillin-resistant S. aureus (MRSA) isolates from infective endocarditis (IE), skin and soft tissue infection (SSTI), and hospital-acquired/ventilator-associated pneumonia (HAP) were matched by geographic origin, then genotyped using spa-typing. In vitro PSM production was measured by high performance liquid chromatography/mass spectrometry. Statistical analysis was performed using Chi-squared or Kruskal-Wallis tests as appropriate. RESULTS: Spa type 1 was significantly more common in SSTI isolates (62.7% SSTI; 1.7% IE; 16.9% HAP; p < 0.0001) while HAP and IE isolates were more commonly spa type 2 (0% SSTI; 37.3% IE; 40.7% HAP; p < 0.0001). USA300 isolates produced the highest levels of PSMs in vitro. SSTI isolates produced significantly higher quantities of PSMα1-4, PSMβ1, and δ-toxin than other isolates (p < 0.001). These findings persisted when USA300 isolates were excluded from analysis. CONCLUSIONS: Increased in vitro production of PSMs is associated with an SSTI clinical source. This significant association persisted after exclusion of USA300 genotype isolates from analysis, suggesting that PSMs play a particularly important role in the pathogenesis of SSTI as compared to other infection types.
BACKGROUND:Phenol-soluble modulins (PSMs) are amphipathic, pro-inflammatory proteins secreted by most Staphylococcus aureus isolates. This study tested the hypothesis that in vitro PSM production levels are associated with specific clinical phenotypes. METHODS: 177 methicillin-resistant S. aureus (MRSA) isolates from infective endocarditis (IE), skin and soft tissue infection (SSTI), and hospital-acquired/ventilator-associated pneumonia (HAP) were matched by geographic origin, then genotyped using spa-typing. In vitro PSM production was measured by high performance liquid chromatography/mass spectrometry. Statistical analysis was performed using Chi-squared or Kruskal-Wallis tests as appropriate. RESULTS: Spa type 1 was significantly more common in SSTI isolates (62.7% SSTI; 1.7% IE; 16.9% HAP; p < 0.0001) while HAP and IE isolates were more commonly spa type 2 (0% SSTI; 37.3% IE; 40.7% HAP; p < 0.0001). USA300 isolates produced the highest levels of PSMs in vitro. SSTI isolates produced significantly higher quantities of PSMα1-4, PSMβ1, and δ-toxin than other isolates (p < 0.001). These findings persisted when USA300 isolates were excluded from analysis. CONCLUSIONS: Increased in vitro production of PSMs is associated with an SSTI clinical source. This significant association persisted after exclusion of USA300 genotype isolates from analysis, suggesting that PSMs play a particularly important role in the pathogenesis of SSTI as compared to other infection types.
Authors: Min Li; Binh An Diep; Amer E Villaruz; Kevin R Braughton; Xiaofei Jiang; Frank R DeLeo; Henry F Chambers; Yuan Lu; Michael Otto Journal: Proc Natl Acad Sci U S A Date: 2009-03-17 Impact factor: 11.205
Authors: Shu Y Queck; Max Jameson-Lee; Amer E Villaruz; Thanh-Huy L Bach; Burhan A Khan; Daniel E Sturdevant; Stacey M Ricklefs; Min Li; Michael Otto Journal: Mol Cell Date: 2008-10-10 Impact factor: 17.970
Authors: Gordon Y C Cheung; Kevin Rigby; Rong Wang; Shu Y Queck; Kevin R Braughton; Adeline R Whitney; Martin Teintze; Frank R DeLeo; Michael Otto Journal: PLoS Pathog Date: 2010-10-07 Impact factor: 6.823
Authors: David R Murdoch; G Ralph Corey; Bruno Hoen; José M Miró; Vance G Fowler; Arnold S Bayer; Adolf W Karchmer; Lars Olaison; Paul A Pappas; Philippe Moreillon; Stephen T Chambers; Vivian H Chu; Vicenç Falcó; David J Holland; Philip Jones; John L Klein; Nigel J Raymond; Kerry M Read; Marie Francoise Tripodi; Riccardo Utili; Andrew Wang; Christopher W Woods; Christopher H Cabell Journal: Arch Intern Med Date: 2009-03-09
Authors: In-Gyu Bae; Giang T Tonthat; Martin E Stryjewski; Thomas H Rude; Lindsay F Reilly; Steven L Barriere; Fredric C Genter; G Ralph Corey; Vance G Fowler Journal: J Clin Microbiol Date: 2009-10-21 Impact factor: 5.948
Authors: In-Gyu Bae; Jerome J Federspiel; José M Miró; Christopher W Woods; Lawrence Park; Michael J Rybak; Thomas H Rude; Suzanne Bradley; Suzana Bukovski; Cristina Garcia de la Maria; Souha S Kanj; Tony M Korman; Francesc Marco; David R Murdoch; Patrick Plesiat; Marta Rodriguez-Creixems; Porl Reinbott; Lisa Steed; Pierre Tattevin; Marie-Françoise Tripodi; Karly L Newton; G Ralph Corey; Vance G Fowler Journal: J Infect Dis Date: 2009-11-01 Impact factor: 5.226
Authors: M Michal Peterson; Jessica L Mack; Pamela R Hall; Anny A Alsup; Susan M Alexander; Erin K Sully; Youhanna S Sawires; Ambrose L Cheung; Michael Otto; Hattie D Gresham Journal: Cell Host Microbe Date: 2008-12-11 Impact factor: 21.023
Authors: Ethan Rubinstein; Tahaniyat Lalani; G Ralph Corey; Zeina A Kanafani; Esteban C Nannini; Marcelo G Rocha; Galia Rahav; Michael S Niederman; Marin H Kollef; Andrew F Shorr; Patrick C Lee; Arnold L Lentnek; Carlos M Luna; Jean-Yves Fagon; Antoni Torres; Michael M Kitt; Fredric C Genter; Steven L Barriere; H David Friedland; Martin E Stryjewski Journal: Clin Infect Dis Date: 2011-01-01 Impact factor: 9.079
Authors: Gordon Y C Cheung; Dorothee Kretschmer; Anthony C Duong; Anthony J Yeh; Trung V Ho; Yan Chen; Hwang-Soo Joo; Barry N Kreiswirth; Andreas Peschel; Michael Otto Journal: PLoS Pathog Date: 2014-08-21 Impact factor: 6.823
Authors: Shu Y Queck; Burhan A Khan; Rong Wang; Thanh-Huy L Bach; Dorothee Kretschmer; Liang Chen; Barry N Kreiswirth; Andreas Peschel; Frank R Deleo; Michael Otto Journal: PLoS Pathog Date: 2009-07-31 Impact factor: 6.823
Authors: Maria Souli; Felicia Ruffin; Seong-Ho Choi; Lawrence P Park; Shengli Gao; Nicholas Christopoulos Lent; Batu K Sharma-Kuinkel; Joshua T Thaden; Stacey A Maskarinec; Lisa Wanda; Jonathan Hill-Rorie; Bobby Warren; Brenda Hansen; Vance G Fowler Journal: Clin Infect Dis Date: 2019-11-13 Impact factor: 9.079
Authors: Stuart W McKellar; Ivayla Ivanova; Pedro Arede; Rachel L Zapf; Noémie Mercier; Liang-Cui Chu; Daniel G Mediati; Amy C Pickering; Paul Briaud; Robert G Foster; Grzegorz Kudla; J Ross Fitzgerald; Isabelle Caldelari; Ronan K Carroll; Jai J Tree; Sander Granneman Journal: Nat Commun Date: 2022-06-22 Impact factor: 17.694
Authors: Robert Qi; Hwang-Soo Joo; Batu Sharma-Kuinkel; Nicholas R Berlon; Lawrence Park; Chih-Lung Fu; Julia A Messina; Joshua T Thaden; Qin Yan; Felicia Ruffin; Stacey Maskarinec; Bobby Warren; Vivian H Chu; Claudio Q Fortes; Efthymia Giannitsioti; Emanuele Durante-Mangoni; Zeina A Kanafani; Michael Otto; Vance G Fowler Journal: J Infect Date: 2016-01-09 Impact factor: 6.072
Authors: Elisabeth Hodille; Charlotte Cuerq; Cédric Badiou; Françoise Bienvenu; Jean-Paul Steghens; Régine Cartier; Michèle Bes; Anne Tristan; Adriana Plesa; Vien T M Le; Binh A Diep; Gérard Lina; Oana Dumitrescu Journal: Front Cell Infect Microbiol Date: 2016-12-12 Impact factor: 5.293
Authors: Matthew R Sinclair; Maria Souli; Felicia Ruffin; Lawrence P Park; Michael Dagher; Emily M Eichenberger; Stacey A Maskarinec; Joshua T Thaden; Michael Mohnasky; Christina M Wyatt; Vance G Fowler Journal: Am J Kidney Dis Date: 2021-07-23 Impact factor: 8.860